A paper published this week in the JAMA Network Open medical journal spotlights the use of six herbal supplements frequently associated with potential hepatotoxic effects. The reliability of the data, approach, conclusions and call to action quickly came...
Taiwan's Greenyn Biotechnology is working to get regulatory approvals in key Asia markets for Antrodia cinnamomea, after the so-called 'miracle mushroom' was found to improve the liver function of regular drinkers and chronic Hep B patients...
A new paper reports a small number of cases of liver injury associated with turmeric supplements, but independent experts tell us that any such phenomena appear to be “rare”, and noted that the botanical has a low risk profile.
New research is shedding light on why some dietary supplement users suffer liver injury from some common products while most consumers do not. This latest information was shared at a prominent botanical science conference at the University of Mississippi.
A new study has found potentially interesting effects on non alcoholic fatty liver disease from geniposide, a rarely studies compound derived from a gardenia species.
The director general of New Zealand's Ministry of Health has issued yet another public warning about supplements containing Artemisia annua extract, after 11 more reports of liver complications from consuming such products surfaced.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA)
is introducing warnings labels for black cohosh products on
potential liver damage, following reports from two committees that
have reviewed the safety data...
The debate over the safety of the popular herbal supplement kava
kava continued yesterday with the announcement by the US Food &
Drug Adminstration that there was a risk of liver damage associated
with the product.
Researchers at the University of Miami are to carry out a trial
testing the safety and effectiveness of a herbal pill designed to
treat the symptoms of menopause
